Chimeric MAb 31.1 (International Bioimmune Systems)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameChimeric MAb 31.1 (International Bioimmune Systems)
Drug Alias Namecolon tumor MAb (IBS)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInternational Bioimmune Systems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInternational Bioimmune Systems IncPurdue Pharma Inc
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A